-+ 0.00%
-+ 0.00%
-+ 0.00%
T. Rowe Price (TROW) Stock Still Looks Below Fair Value After 33% Fall
Share
Listen to the news

T. Rowe Price Group has seen its share price move around over the past few years, and that raises a simple but important issue for you as an investor. Is the current valuation really supported by the returns the asset manager earns on the capital it puts to work?

  • Over the past 5 years, T. Rowe Price Group shareholders have seen the stock decline 33.3%, which puts the focus squarely on whether the underlying return on capital profile justifies where the shares trade today.
  • The recent push into new actively managed ETFs and the broader use of AI tools across its investment process can influence how efficiently T. Rowe Price turns its research spend and balance sheet into future fee income and returns on invested capital.
  • Prefer to judge T. Rowe Price Group on earnings? See what T. Rowe Price Group's 10.3x P/E says about the price.

The stock's next move may depend on whether the returns T. Rowe Price Group earns on its capital are strong enough to make today's price look sensible.

Before getting too focused on T. Rowe Price Group alone, it can help to compare it with a wider set of asset managers and capital market stocks that meet the same quality filters that power the 30 high quality undervalued stocks.

Is T. Rowe Price Group a Bargain on Excess Returns?

The Excess Returns model looks at how much profit T. Rowe Price Group can earn above its cost of equity on each dollar of shareholder capital. On this view, the stock market is paying $104.57 for a business where book value sits at $51.58 per share and the average return on equity is 18.88%, which is comfortably higher than the cost of equity that the model converts into $4.18 of required earnings per share.

That spread is what drives the estimated excess return of $5.80 per share on a stable EPS figure of $9.98, with growth in the underlying book value projected to settle around $52.85 per share. The recent rollout of new actively managed biotech, small cap and mid cap ETFs gives T. Rowe Price another way to put that equity base to work, and despite those extensions into fresh product lines, the Excess Returns framework still points to an intrinsic value substantially above $104.57. Find out what T. Rowe Price Group could be worth using our Excess Returns estimate.

The T. Rowe Price Group Narrative: What Would Justify Today's Price?

Narratives for T. Rowe Price Group pick up where the valuation question leaves off and explain what kind of future earnings power, margin profile and growth path would need to occur for the share price to look meaningfully higher or lower than it is today. They use simple storylines that turn a single output from a model or ratio into a set of assumptions you can follow over time on Simply Wall St's Community page.

Community views on T. Rowe Price Group split between those who see disciplined spending and new products as a quiet advantage and those who focus on fee pressure and tougher active equity flows.

Bull case: roughly fairly valued

"Ongoing investment in technology, digital platforms, and artificial intelligence is expected to increase operational efficiency and client customization at scale…"

Discover why this Narrative puts T. Rowe Price Group at roughly fairly valued.

Bear case: 16% overvalued

"T. Rowe Price Group is experiencing significant fee compression with a higher-than-average rate of 2% in 2024, due to a mix shift in sales towards lower-fee vehicles…"

Explore why this Narrative puts T. Rowe Price Group at 16% overvalued.

One more check for T. Rowe Price Group before you stop at the share price

The next question is who is actually steering T. Rowe Price Group and how their pay packets line up with the outcomes you care about as a shareholder. See who runs T. Rowe Price Group and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending